Tom Wilde is currently the Head of Pharmacometrics at Recursion, a role they began in 2024. Prior to this, they held the position of Director of DMPK at Exscientia from 2022 to 2024 and served as a Senior Principal Scientist at the Janssen Pharmaceutical Companies of Johnson & Johnson from 2019 to 2022, specializing in mechanistic PK/PD modeling for drug discovery in various therapeutic areas. Tom has a strong academic background, having earned a Ph.D. in Chemistry/Biochemistry from the University of Maryland Baltimore County and a BS in Chemistry from the University of Virginia. Their early career included impactful roles at the National Cancer Institute and GlaxoSmithKline, focusing on cancer research and DMPK science.
This person is not in the org chart
This person is not in any teams
This person is not in any offices